ACXP
Income statement / Annual
Last year (2023), Acurx Pharmaceuticals, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Acurx Pharmaceuticals, Inc.'s net income was -$14.58 M.
See Acurx Pharmaceuticals, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$6.04 M
|
$4.75 M
|
$2.03 M
|
$2.20 M
|
$3.51 M
|
| General & Administrative
Expenses |
$8.53 B
|
$7.34 M
|
$10.78 M
|
$2.40 M
|
$2.42 M
|
| Selling & Marketing
Expenses |
-$8.53 B
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$8.53 M
|
$7.34 M
|
$10.78 M
|
$2.40 M
|
$2.42 M
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$14.58 M |
$12.09 M |
$12.81 M |
$4.60 M |
$5.93 M |
| Cost And Expenses |
$14.58 M |
$12.09 M |
$12.81 M |
$4.60 M |
$5.93 M |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$14.58 M
|
$12.09 M
|
$12.81 M
|
$4.60 M
|
$5.93 M
|
| EBITDA |
$0.00
|
-$12.09 M
|
$0.00
|
-$4.60 M
|
-$5.93 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$0.00
|
-$1.00
|
$66,502.00
|
$0.00
|
$0.00
|
| Income Before Tax |
-$14.58 M |
-$12.09 M |
-$12.75 M |
-$4.60 M |
-$5.93 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$1,224.00 |
-$66,503.00 |
-$4,598.04 |
-$5,934.25 |
| Net Income |
-$14.58 M |
-$12.09 M |
-$12.68 M |
-$4.60 M |
-$5.93 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
| EPS |
-1.15 |
-1.12 |
-1.24 |
-0.46 |
-0.6 |
| EPS Diluted |
-1.15 |
-1.12 |
-1.24 |
-0.46 |
-0.6 |
| Weighted Average Shares
Out |
$12.67 M
|
$10.82 M
|
$10.22 M
|
$9.92 M
|
$9.92 M
|
| Weighted Average Shares
Out Diluted |
$12.67 M
|
$10.82 M
|
$10.22 M
|
$9.92 M
|
$9.92 M
|
| Link |
|
|
|
|
|
